During the past decade, Greensboro Imaging conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Greensboro Imaging" are "Arthritis" (1 trials), "Low Back Pain" (1 trials), "Osteoarthritis" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "Greensboro Imaging" in a lesser frequency.

Most popular intervention types in "Greensboro Imaging" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo IV" (1 trials), "Placebo SC" (1 trials), "Tanezumab 10 mg" (1 trials), "Tanezumab 20 mg" (1 trials) and "Tanezumab IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Greensboro Imaging" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Greensboro Imaging". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Greensboro Imaging, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Greensboro Imaging, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".